PRDM2 and cervical cancer: Taken together, down-regulation of RIZ1 expression may contribute to tumor migration and invasiveness, as well as poor survival of cervical cancer patients, suggesting that RIZ1 may be a novel prognostic biomarker for cervical cancer.